UCB SA (LON:0NZT)
184.10
-13.00 (-6.60%)
At close: Aug 1, 2025
UCB SA Employees
As of December 31, 2024, UCB SA had 9,378 total employees, including 9,052 full-time and 326 part-time employees. The number of employees increased by 295 or 3.25% compared to the previous year.
Employees
9,378
Change (1Y)
295
Growth (1Y)
3.25%
Revenue / Employee
$637,011
Profits / Employee
$123,905
Market Cap
30.62B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9,378 | 295 | 3.25% |
Dec 31, 2023 | 9,083 | 380 | 4.37% |
Dec 31, 2022 | 8,703 | 142 | 1.66% |
Dec 31, 2021 | 8,561 | 190 | 2.27% |
Dec 31, 2020 | 8,371 | 765 | 10.06% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
British American Tobacco p.l.c. | 48,989 |
Rolls-Royce Holdings | 42,400 |
Rio Tinto Group | 60,000 |
RELX PLC | 36,400 |